Haleon PLC Sponsored ADR (NYSE:HLN) to Issue Semi-annual Dividend of $0.06

Key Points

• Haleon PLC has declared a semi-annual dividend of $0.06, representing an 8% increase from its previous dividend of $0.05, with an important ex-dividend date set for August 15th.
• The company maintains a payout ratio of 42.6%, indicating that its dividend is well-covered by earnings, with analysts expecting Haleon to earn $0.49 per share next year.
• Haleon's market cap is approximately $41.78 billion, with shares traded at $9.30, reflecting significant trading activity with nearly 9.4 million shares exchanged recently.

Haleon PLC Sponsored ADR (NYSE:HLN - Get Free Report) declared a semi-annual dividend on Tuesday, August 5th, Wall Street Journal reports. Stockholders of record on Friday, August 15th will be paid a dividend of 0.0555 per share on Thursday, September 18th. This represents a dividend yield of 190.0%. The ex-dividend date of this dividend is Friday, August 15th. This is a 8.0% increase from Haleon's previous semi-annual dividend of $0.05.

Haleon has a payout ratio of 42.6% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Haleon to earn $0.49 per share next year, which means the company should continue to be able to cover its $0.23 annual dividend with an expected future payout ratio of 46.9%.

Haleon Price Performance

Shares of HLN traded down $0.21 during mid-day trading on Tuesday, reaching $9.30. 9,372,880 shares of the company's stock were exchanged, compared to its average volume of 13,281,549. The company has a quick ratio of 0.78, a current ratio of 0.98 and a debt-to-equity ratio of 0.53. The company has a 50-day simple moving average of $10.34 and a two-hundred day simple moving average of $10.20. Haleon has a 52-week low of $8.86 and a 52-week high of $11.42. The company has a market cap of $41.78 billion, a price-to-earnings ratio of 23.85, a PEG ratio of 2.79 and a beta of 0.23.

Institutional Investors Weigh In On Haleon

Institutional investors and hedge funds have recently bought and sold shares of the business. Private Trust Co. NA boosted its holdings in shares of Haleon by 13.3% in the second quarter. Private Trust Co. NA now owns 8,794 shares of the company's stock valued at $91,000 after acquiring an additional 1,032 shares in the last quarter. Farther Finance Advisors LLC boosted its holdings in shares of Haleon by 8.8% in the first quarter. Farther Finance Advisors LLC now owns 12,861 shares of the company's stock valued at $131,000 after acquiring an additional 1,041 shares in the last quarter. Apollon Wealth Management LLC boosted its holdings in shares of Haleon by 5.4% in the first quarter. Apollon Wealth Management LLC now owns 21,722 shares of the company's stock valued at $224,000 after acquiring an additional 1,111 shares in the last quarter. Simplicity Wealth LLC boosted its holdings in shares of Haleon by 7.9% in the first quarter. Simplicity Wealth LLC now owns 15,482 shares of the company's stock valued at $159,000 after acquiring an additional 1,135 shares in the last quarter. Finally, Holistic Financial Partners boosted its holdings in shares of Haleon by 9.6% in the first quarter. Holistic Financial Partners now owns 13,379 shares of the company's stock valued at $138,000 after acquiring an additional 1,172 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company's stock.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.